Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study
There is no approved drug for fibromyalgia syndrome (FMS) in Europe. In the German S3 guideline, amitriptyline, duloxetine, and pregabalin are recommended for temporary use. The aim of this study was to cross-sectionally investigate the current practice of medication in FMS patients in Germany. We s...
Saved in:
| Main Authors: | H.-C. Aster, D. Evdokimov, A. Braun, N. Üçeyler, C. Sommer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2022/1217717 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Small fiber pathology in fibromyalgia syndrome
by: Claudia Sommer, et al.
Published: (2025-02-01) -
Knowledge, attitude and practice toward fibromyalgia among fibromyalgia patients: A web-based cross-sectional study in China
by: Dongfeng Liang, et al.
Published: (2024-12-01) -
Chronic pain, fibromyalgia, and long COVID
by: Jürgen Braun
Published: (2025-01-01) -
Demographic Characteristics and Inflammatory Biomarker Profile in Psoriatic Arthritis Patients with Comorbid Fibromyalgia: A Cross-Sectional Study
by: Marino Paroli, et al.
Published: (2025-06-01) -
The impact of a heat therapy intervention on pain and fibromyalgia symptoms in patients with fibromyalgia: a pilot study
by: Andrea L. Chadwick, et al.
Published: (2025-03-01)